Oxford-AstraZeneca COVID-19 Vaccine Trials Resume in UK

Oxford University on September 12 confirmed that the trials of the COVID-19 vaccine, which is being developed in collaboration with AstraZeneca, has been resumed in UK. The university stated, "Following the recommendations of both the independent safety review committee and the UK regulator, trials will recommence." The vaccine is now in phase-3 trials and was halted on September 8 owing to an adverse reaction in one of the participants.